On the recordFebruary 3, 2016
In 2009, this committee passed the Biologics Price Competition and Innovation Act (BPCIA) by a vote of 47 to 11.
Source
congress.govIn 2009, this committee passed the Biologics Price Competition and Innovation Act (BPCIA) by a vote of 47 to 11.
Pitts references the committee's bipartisan support for the BPCIA.
Share
More from Joe Pitts
H.R. 1807, the Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015, sponsored by Rep. Danny Davis (IL) and Rep. Michael Burgess (TX) reauthorizes a sickle cell disease demonstration program.
Parity means that insurers need to treat copayments, treatment limits, prior authorization for mental health, substance use disorder the same way they treat for physical health care.
H.R. 3119, the Palliative Care and Hospice Education and Training Act, sponsored by Rep. Engel (NY) increases the number of permanent faculty in palliative care.